IndraLab

Statements


| 2 2

reach
"Additionally, given the potential regulatory interactions between FOXO3a and USP18, combination therapies targeting both molecules simultaneously might offer synergistic benefits."

reach
"Conclusion Deciphering the complex molecular interactions between FOXO3a and USP18 in fibroblasts provides a deeper understanding of IPF pathogenesis and unveils novel therapeutic avenues, offering a promising potential for not just halting but potentially reversing the progression of this debilitating disease."

sparser
"Conclusion  Deciphering the complex molecular interactions between FOXO3a and USP18 in fibroblasts provides a deeper understanding of IPF pathogenesis and unveils novel therapeutic avenues, offering a promising potential for not just halting but potentially reversing the progression of this debilitating disease."

sparser
"Additionally, given the potential regulatory interactions between FOXO3a and USP18, combination therapies targeting both molecules simultaneously might offer synergistic benefits."